FDA reviewer backs Bristol's Avalide as first-line treatment

04/17/2007 | Reuters · Wall Street Journal, The

An FDA reviewer recommended the agency approve Bristol-Myers Squibb's Avalide as a first-line treatment for hypertension, promoting it from its second-line status. The reviewer, whose work was posted on the FDA Web site ahead of an advisory panel meeting on the drug, said the treatment was "highly effective" in treating moderate to severe hypertension.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ